The first disorders caused by mutations permitting enhanced Cav1.3 Ca2+ channel activity were discovered as somatic CACNA1D missense mutations in, typically benign, aldosterone‐producing adrenal adenomas (APAs) in patients with primary aldosteronism (Azizan et al. This evidence concerns the gene CACNA1D and primary aldosteronism.